[{"address1": "Level 10", "address2": "Tower 11 Avenue 5, No. 8 Jalan Kerinchi", "city": "Kuala Lumpur", "zip": "592000", "country": "Malaysia", "phone": "60 9 08517 7330", "website": "https://www.cyclacel.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Cyclacel Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops cancer medicines based on cell cycle, transcriptional regulation, epigenetics, and mitosis control biology in the United States. Its lead product Plogosertib or plogo, a solid tumors and hematological malignancies, which is in Phase 1/2 clinical trial. The company was founded in 1996 and is headquartered in Kuala Lumpur, Malaysia.", "companyOfficers": [{"maxAge": 1, "name": "Dr. Sing Ee Wong", "age": 43, "title": "Chairman, CEO & President", "yearBorn": 1981, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Cu Seng Kiu", "age": 34, "title": "Executive Director, CFO & Secretary", "yearBorn": 1990, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Gill  Christie", "age": 67, "title": "Director of Human Resources", "yearBorn": 1957, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Grace  Kim", "title": "Investor Relations Executive", "exercisedValue": 0, "unexercisedValue": 0}], "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 0.3498, "open": 0.342, "dayLow": 0.3242, "dayHigh": 0.353, "regularMarketPreviousClose": 0.3498, "regularMarketOpen": 0.342, "regularMarketDayLow": 0.3242, "regularMarketDayHigh": 0.353, "payoutRatio": 0.0, "beta": 0.247, "trailingPE": 0.11493055, "forwardPE": -0.16633166, "volume": 457870, "regularMarketVolume": 457870, "averageVolume": 1455027, "averageVolume10days": 3635530, "averageDailyVolume10Day": 3635530, "bid": 0.3, "ask": 0.0, "bidSize": 1, "askSize": 0, "marketCap": 7864394, "fiftyTwoWeekLow": 0.25, "fiftyTwoWeekHigh": 39.84, "priceToSalesTrailing12Months": 561.74243, "fiftyDayAverage": 2.2016, "twoHundredDayAverage": 6.568, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 3931146, "profitMargins": 0.0, "floatShares": 747237, "sharesOutstanding": 23759500, "sharesShort": 595114, "sharesShortPriorMonth": 30021, "sharesShortPreviousMonthDate": 1747267200, "dateShortInterest": 1749772800, "sharesPercentSharesOut": 0.025, "heldPercentInsiders": 0.61492, "heldPercentInstitutions": 0.06637, "shortRatio": 0.26, "shortPercentOfFloat": 0.8168, "impliedSharesOutstanding": 23759500, "bookValue": 0.236, "priceToBook": 1.4025424, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1743379200, "netIncomeToCommon": -8347000, "trailingEps": 2.88, "forwardEps": -1.99, "lastSplitFactor": "1:16", "lastSplitDate": 1747008000, "enterpriseToRevenue": 280.796, "enterpriseToEbitda": -0.31, "52WeekChange": -0.9872685, "SandP52WeekChange": 0.12748289, "lastDividendValue": 2.4, "lastDividendDate": 1745884800, "quoteType": "EQUITY", "currentPrice": 0.331, "recommendationKey": "none", "totalCash": 3450000, "totalCashPerShare": 0.155, "ebitda": -12679500, "totalDebt": 9000, "quickRatio": 5.204, "currentRatio": 5.602, "totalRevenue": 14000, "debtToEquity": 0.294, "revenuePerShare": 0.001, "returnOnAssets": -1.6018, "returnOnEquity": -19.50234, "grossProfits": 14000, "freeCashflow": -11783125, "operatingCashflow": -10754000, "grossMargins": 1.0, "ebitdaMargins": 0.0, "operatingMargins": -906.0714, "financialCurrency": "USD", "symbol": "CYCC", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1079447400000, "postMarketChangePercent": 0.694862, "postMarketPrice": 0.3333, "postMarketChange": 0.00229999, "regularMarketChange": -0.0188, "regularMarketDayRange": "0.3242 - 0.353", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 1455027, "fiftyTwoWeekLowChange": 0.081, "fiftyTwoWeekLowChangePercent": 0.324, "fiftyTwoWeekRange": "0.25 - 39.84", "fiftyTwoWeekHighChange": -39.509, "fiftyTwoWeekHighChangePercent": -0.9916917, "fiftyTwoWeekChangePercent": -98.72685, "dividendDate": 1746057600, "earningsTimestamp": 1747284600, "earningsTimestampStart": 1754996340, "earningsTimestampEnd": 1755518400, "earningsCallTimestampStart": 1723667400, "earningsCallTimestampEnd": 1723667400, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": 2.88, "epsForward": -1.99, "fiftyDayAverageChange": -1.8706001, "fiftyDayAverageChangePercent": -0.8496548, "twoHundredDayAverageChange": -6.237, "twoHundredDayAverageChangePercent": -0.94960415, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "cryptoTradeable": false, "marketState": "CLOSED", "regularMarketChangePercent": -5.3745, "regularMarketPrice": 0.331, "corporateActions": [], "postMarketTime": 1751066056, "regularMarketTime": 1751054402, "exchange": "NCM", "messageBoardId": "finmb_125004", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "shortName": "Cyclacel Pharmaceuticals, Inc.", "longName": "Cyclacel Pharmaceuticals, Inc.", "displayName": "Cyclacel Pharmaceuticals", "trailingPegRatio": null, "__fetch_time": "2025-06-28"}]